Navigation Links
Leaders from Pfizer, Novartis and J&J Challenge Industry to Disrupt R&D
Date:8/8/2012

NEW YORK, Aug. 8, 2012 /PRNewswire/ -- Pharmaceutical and biotech companies are preparing to hear more than 25 presentations, ranging from key behaviors that drive innovation to applying disruptive approaches to achieve pragmatic clinical trials, at the 2nd Annual Disruptive Innovations to Advance Clinical Trials (DPharm) conference. The event is scheduled for September 13-14, 2012 at the Fairmont Copley Plaza Hotel, Boston, MA. www.dpharmconference.com

Designed for innovative thinkers looking to take the high-level, systemic view needed to identify changes that can overcome inefficiencies in clinical trials, this TED-style event showcases innovations and leading practitioners in clinical research. Leading the event is:

  • Craig H. Lipset, Head of Clinical Innovation, Research & Development, Pfizer
  • John Orloff, MD, SVP, Global Development & Chief Medical Officer, Novartis Pharma AG
  • Andreas Koester, MD, PhD, VP, Clinical Trial Innovation & External Alliances, Janssen, Pharmaceutical Companies of Johnson & Johnson

"Featuring fresh ideas in a highly engaging format, DPharm has quickly emerged as THE event for creative leaders seeking to bring the changes in clinical research necessary to ensure the ongoing development of new medicines," comments Craig Lipset.

Co-Chair John Orloff adds, "The pharmaceutical industry is at a crossroads.  We can cling to the old business model and go the way of the dinosaurs. Or we can embrace disruptive technologies and innovations, already being piloted, to transform our industry and move us into a new era of productivity, for our patients. Do we have the will and the bold leadership to make it happen?  The 2nd Annual DPharm event discusses many of these opportunities as a catalyst towards a new paradigm."

As a Guest VIP Speaker, Karen Freidt, Lead, Navigation Center for Creativity, Collaboration & Innovation, NASA, talks about how NASA powers innovation in a heavily regulated high risk industry.

Over 250 attendees are anticipated. Companies participating in the event include Acorda Therapeutics, AG Mednet, Aptiv Solutions, Archimedes, AxxiTRIALS, Bill & Melinda Gates Foundation, Celtic Therapeutics, Clinical Ink, DrugDev.org, Eli Lilly, Endo Pharmaceuticals, Esperion Therapeutics, Geisinger Health System, GSK, Janssen, Merck Research Laboratories (MRL), Milestone Venture Partners, Novartis Pharma AG, Pfizer, J&J, NASA, RPS, Shire, Spaulding Clinical, Structural Genomics Consortium, Symphony Clinical Research, Target Health Inc., Transparency Life Sciences, ?WhatIf! Innovation and many more.

For more information, visit www.theconferenceforum.org, email Chealy@theconferenceforum.org or call 646 350 2580.

MEDIA CONTACT: Ciara Healy, PH: 646-350-2580 x310, Email: Chealy@theconferenceforum.org


'/>"/>
SOURCE The Conference Forum
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. PharmaVOICE Names Four inVentiv Health Associates Among "100 Most Inspiring" Leaders in Healthcare
2. Two Baltimore Business Leaders are BioHealth Innovation, Inc.s Newest Board Members
3. Advanced Animal Diagnostics Adds Sales & Marketing Leadership
4. Bio-Innovator Saneron CCEL Therapeutics Supports Cryo-Cell International Leadership and Board of Directors in Proxy Contest
5. GenScript Honored with the 2012 CRO Leadership Award
6. Innovation Leaders from Across Industries will Convene to Share Best Practices and Breakthrough Successes at Open Innovation Leadership Summit
7. BioMotiv Launches Novel Drug Development Operation, Names Leadership Team
8. CAS Names 2012 SciFinder® Future Leaders in Chemistry Program Participants
9. Oncobiologics Fills Key Leadership Positions and Names Scientific Advisory Board
10. MD&M East 2012 to Feature FDA and Medical Technology Development Leaders
11. USC Marshall School of Business 6th Annual Leadership Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
(Date:2/23/2017)... 2017  Imanis Life Sciences announced today the ... vaccinia viruses for virotherapy research. These viruses are ... proprietary, vaccinia virus-based technology platform for research use. ... a partnership with Genelux to offer researchers, for ... use in research," said Dr. Kah Whye ...
(Date:2/23/2017)... Ind. (PRWEB) , ... February 23, 2017 , ... ... Award during the 12th annual Inventors Recognition Reception at Purdue Research Park ... to a faculty member in recognition of outstanding contributions to, and success with, ...
(Date:2/23/2017)... -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing biological ... Linda Marb├ín, Ph.D, president and chief executive officer, is scheduled ... Cowen and Company 37th Annual Health Care Conference Tuesday, ... MA 29th Annual ROTH Conference ... ET) Dana Point, CA ...
Breaking Biology Technology:
(Date:2/1/2017)... IDTechEx Research, a leading provider of independent ... availability of a new report, Sensors for Robotics: Technologies, Markets ... ... ... IDTechEx Report "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: Machine ...
(Date:1/25/2017)... , Jan. 25, 2017 The Elements ... Management (IAM) lifecycle is comprised of a comprehensive ... the purpose of maintaining digital identities and providing ... and applications. There are significant number of programs ... time to time by optimizing processes and changing ...
(Date:1/19/2017)... and PUNE, India , January 19, 2017 ... "Global Biometric Sensor Market, Opportunities and Forecast, 2014 - 2022," the global ... a CAGR of 9.6% from 2016 to 2022. In 2015, Asia-Pacific ... high-level security for both public and private sectors. ... ...
Breaking Biology News(10 mins):